Key Players
Competitive Landscape
Competition in China’s medical tourism runs between foreign-invested hospital groups, domestic private hospitals, public hospitals with international departments and the Hainan pilot zone, which offers access to treatments that are not otherwise available in China. Patients and facilitators compare them on the clinical offer, the language and insurance support available and the clarity of the follow-up arrangements.
Cost and access are the points that separate them in 2026. United Family Healthcare points to CAR-T therapy costing about one-half to one-third of similar treatment in the United States, which has been in clinical application in China since 2017, [4] while the Hainan zone competes on the range of products it can offer not on price. Providers that explain who handles each step of the journey are best placed to convert enquiries from abroad into bookings.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| September 2026: Jiahui Health’s chairman addressed the WTO Public Forum in Geneva on medical tourism and services trade. [3] | Overseas patient inquiries nearly doubled year on year in the first half of 2026. | More than 100,000 international outpatient visits in 2025. | International insurance direct billing, remote consultation and multilingual coordination. |
| March 2026: United Family Healthcare said foreign patient numbers at Beijing United Family Hospital have continued to rise. [4] | Direct-billing agreements with dozens of insurers worldwide. | Patient needs have moved towards complex cancer and rare disease treatment. | CAR-T therapy at about one-half to one-third of the United States cost, according to the hospital. |
| February 2026: Shenzhen Qianhai Taikang Hospital reported foreign patient visits up 130% in January 2026 against its monthly average since opening. [5] | Total visits grew 73% over the same period. | The hospital opened in August 2024. | More hospital capacity aimed at international patients. |
| August 2026: The Boao Lecheng pilot zone reported 640,800 medical-tourism visitors in the first half of 2026, up 133%. [2] | More than 600 types of specially approved drugs, devices and special foods are available. | Nearly 8,000 of the visitors were overseas tourists. | A China-ROK agreement on coordinated medical tourism development. |
Source: Future Market Insights analysis, 2026 to 2036.
Company updates show that access to treatment and clear support for foreign patients separate the leading providers in 2026. Providers that pair a defined clinical offer with a named contact for travel and follow-up are best placed to hold international enquiries.
How are key market participants positioned in the China medical tourism market?
United Family Healthcare was founded in Beijing in 1997 as the healthcare services arm of Chindex International and is described as China’s first foreign-invested for-profit healthcare provider. [4] Jiahui Health serves international patients with direct billing and remote consultation, [3] Shenzhen Qianhai Taikang Hospital opened in August 2024, [5] and the Boao Lecheng zone brings more than 20 medical institutions with international clinics together under special access policies. [6]
What qualification or purchasing requirements matter most to prospective buyers?
International patients look for a provider that can handle language, payment and visa needs before departure and keep records and advice available afterwards. They compare the clinical offer with the support included in the booking and the person who will answer questions after they return home.
Which product or service capabilities distinguish the leading companies?
Jiahui Health cited a New Zealand patient who became the first international recipient of a newly approved CAR-T therapy and a U.S. patient who travelled for ivonescimab, which it said is currently available only in China. [3] United Family Healthcare’s direct-billing agreements with dozens of insurers remove the need for large deposits. [4]
How does geographic reach differ among the leading companies?
The Boao Lecheng zone draws on visa-free entry for travelers from dozens of countries and regions, [6] while Jiahui Health cited a 240-hour visa-free transit policy open to citizens of 57 countries. [3] Beijing United Family Hospital and Shenzhen Qianhai Taikang Hospital serve patients in their own cities. [4][5]
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| United Family Healthcare | First foreign-invested for-profit healthcare provider in China, founded in Beijing in 1997. [4] | Its general manager said in March 2026 that foreign patient numbers at Beijing United Family Hospital have continued to rise. [4] |
| Jiahui Health | Private hospital group serving international patients with direct billing and remote consultation. [3] | Recorded more than 100,000 international outpatient visits in 2025 and nearly doubled overseas inquiries in the first half of 2026. [3] |
| Shenzhen Qianhai Taikang Hospital | Hospital in Shenzhen that opened in August 2024. [5] | Reported foreign patient visits up 130% in January 2026 against its monthly average since opening. [5] |
| Boao Lecheng pilot zone | Hainan pilot zone for international medical tourism with special access policies. [6] | Reported 640,800 medical-tourism visitors in the first half of 2026, up 133%. [2] |
Research Methodology
The China medical tourism market assessment was conducted using primary interviews and secondary literature analysis combined with top-down data triangulation to validate market size, segment shares, and competitive positioning.
